John A Thompson Selected Research

BHTOH-QM

10/2005

Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John A Thompson Research Topics

Disease

61	Neoplasms (Cancer) 11/2022 - 04/2002
55	Melanoma (Melanoma, Malignant) 11/2022 - 04/2002
24	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 09/2003
8	Parkinson Disease (Parkinson's Disease) 05/2022 - 06/2017
8	Diarrhea 01/2021 - 08/2009
6	Fatigue 01/2021 - 08/2002
6	Colitis 01/2021 - 09/2009
6	Carcinoma (Carcinomatosis) 01/2019 - 07/2006
5	Disease Progression 01/2021 - 12/2009
5	Neoplasm Metastasis (Metastasis) 11/2018 - 08/2002
5	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 07/2006
5	Carcinogenesis 07/2011 - 03/2003
4	Movement Disorders (Movement Disorder) 08/2022 - 01/2014
4	Pneumonia (Pneumonitis) 01/2017 - 08/2008
4	Inflammation (Inflammations) 08/2012 - 11/2003
3	Glioma (Gliomas) 01/2022 - 09/2017
3	Drug Resistant Epilepsy 01/2022 - 04/2018
3	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2010
3	Merkel Cell Carcinoma 01/2018 - 10/2010
3	Exanthema (Rash) 01/2014 - 08/2004
2	Cardiotoxicity 12/2021 - 10/2018
2	Mycosis Fungoides 11/2021 - 07/2002
2	Nausea 01/2021 - 10/2010
2	Stomatitis 01/2021 - 08/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2017
2	Body Weight (Weight, Body) 06/2016 - 08/2002
2	Thrombocytopenia (Thrombopenia) 06/2015 - 12/2011
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2014 - 04/2008
2	Infections 01/2014 - 09/2010
2	Hepatitis B 01/2014 - 07/2013
2	Hypoxia (Hypoxemia) 08/2012 - 08/2003
2	Ischemia 08/2012 - 04/2003

Drug/Important Bio-Agent (IBA)

19	Immune Checkpoint InhibitorsIBA 11/2022 - 09/2014
17	IpilimumabIBA 01/2021 - 02/2009
10	AntigensIBA 01/2018 - 12/2004
9	Interleukin-2 (IL2)IBA 11/2014 - 09/2003
7	Butylated Hydroxytoluene (BHT)IBA 07/2011 - 08/2002
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
6	InterferonsIBA 01/2016 - 08/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2004
5	Dacarbazine (DIC)FDA LinkGeneric 01/2016 - 01/2010
5	Monoclonal AntibodiesIBA 08/2014 - 03/2004
5	Grape Seed ExtractIBA 01/2014 - 07/2006
5	Fibroblast Growth Factor 1 (FGF-1)IBA 07/2005 - 05/2002
4	CytokinesIBA 07/2021 - 06/2008
4	pembrolizumabIBA 10/2020 - 06/2016
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 05/2014
4	EnzymesIBA 01/2016 - 07/2005
4	VaccinesIBA 10/2014 - 04/2002
4	Sunitinib (Sutent)FDA Link 04/2012 - 08/2008
4	Food Additives (Food Additive)IBA 07/2011 - 08/2002
3	Neoplasm Antigens (Tumor Antigens)IBA 11/2022 - 11/2010
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2010
3	NivolumabIBA 01/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2021 - 08/2004
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 08/2002
3	Everolimus FDA Link 10/2016 - 08/2008
3	procyanidin B2IBA 01/2014 - 04/2010
3	interleukin-21 (interleukin 21)IBA 01/2014 - 04/2008
3	Peptides (Polypeptides)IBA 12/2011 - 04/2002
3	Cancer VaccinesIBA 12/2008 - 04/2002
3	AntioxidantsIBA 08/2008 - 10/2005
3	quinone (benzoquinone)IBA 02/2007 - 08/2002
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 08/2003 - 07/2002
2	Methylphenidate (Ritalin)FDA LinkGeneric 05/2022 - 08/2002
2	Biological ProductsIBA 11/2021 - 12/2008
2	Interleukin-15 (Interleukin 15)IBA 11/2021 - 01/2018
2	AGS-16C3FIBA 01/2021 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2017
2	CTLA-4 AntigenIBA 10/2020 - 01/2019
2	talimogene laherparepvecIBA 11/2018 - 01/2016
2	peginterferon alfa-2b (Pegintron)FDA Link 01/2018 - 04/2013
2	Immunoconjugates (Immunoconjugate)IBA 01/2018 - 12/2014
2	SteroidsIBA 01/2017 - 09/2009
2	TOR Serine-Threonine KinasesIBA 10/2016 - 08/2008
2	VemurafenibIBA 01/2016 - 04/2013
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2016 - 12/2005
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 11/2014
2	Interferon alpha-2 (Roferon-A)FDA Link 11/2014 - 05/2007
2	MelacineIBA 10/2014 - 04/2002
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2014 - 04/2002
2	Histocompatibility Antigens Class IIBA 10/2014 - 04/2002
2	RamucirumabIBA 08/2014 - 06/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2014 - 08/2008
2	Imatinib Mesylate (Gleevec)FDA Link 04/2013 - 10/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2012 - 04/2008
2	EstersIBA 03/2012 - 04/2010

Therapy/Procedure

41	Therapeutics 12/2021 - 04/2002
19	Immunotherapy 04/2022 - 04/2002
13	Deep Brain Stimulation 08/2022 - 01/2014
8	Drug Therapy (Chemotherapy) 01/2017 - 07/2002
4	Injections 11/2021 - 08/2002
4	Radiotherapy 01/2021 - 03/2004
3	Electrodes (Electrode) 01/2021 - 06/2017
3	Biological Therapy 11/2014 - 12/2009
3	Cell Transplantation 06/2011 - 12/2004
2	Craniotomy 01/2022 - 01/2022
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 05/2014
2	Implanted Electrodes 01/2020 - 01/2014
2	Kidney Transplantation 08/2012 - 04/2003